Clinical Trial

NeoAdjuvant ChemoTherapy With KELIM Guided Interval vs. Delayed Interval Debulking Surgery

Study acronym: NACT-KELIM ID
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
A prospective, international, multi-center, interventional trial of advanced epithelial ovarian cancer patients offered three cycles of neoadjuvant chemotherapy (NACT) and triaged with KELIM score. Patients with favorable score will undergo interval debulking surgery (IDS) followed by another 3 cycles, while those with unfavorable score will undergo another 3 cycles of NACT followed by delayed interval debulking surgery (DIDS).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-27.
Trial Details
NCT Number NCT07382479
Lead Sponsor Aristotle University Of Thessaloniki
Conditions Ovarian Cancer
Enrollment 485 participants
Start Date 2026-04-01
Primary Completion 2031-04-01 (estimated)
Study Completion 2034-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-05